Inventor

Mark L. Peterson

Inventor
Sherbrooke, CA

Overview

25→
Patents
1992–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 25 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07KPeptides21%
A61KPreparations for medical, dental or toiletry purposes18%
C07DHeterocyclic compounds15%
C07CAcyclic or carbocyclic compounds11%
Y02ATechnologies for adaptation to climate change6%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
C07BGeneral methods of organic chemistry1%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
C40BCombinatorial chemistry1%
PatentTitleYear
10,961,237Inhibiting agents for Bruton's tyrosine kinase202110,407,442Libraries of heteroaryl-containing macrocyclic compounds and methods of making and using the same201910,258,602Macrocyclic ghrelin receptor modulators and methods of using the same201910,040,751Intermediates for macrocyclic compounds20189,949,949Macrocyclic ghrelin receptor modulators and methods of using the same20189,753,019'Measuring nitric oxide in fluid'20179,651,530'Methods and apparatus for measuring nitric oxide in fluid'20179,371,297'Macrocyclic ghrelin receptor modulators and methods of using the same'20169,181,298'Intermediates for macrocyclic compounds'20158,557,765'Spatially-defined macrocycles incorporating peptide bond surrogates'20138,497,242'Processes for intermediates for macrocyclic compounds'20138,450,268'Methods of using macrocyclic modulators of the ghrelin receptor'20138,440,851'Spatially-defined macrocyclic compounds useful for drug discovery'20138,349,887'Methods of treating cachexia with macrocyclic modulators of the ghrelin receptor'20138,088,733'Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders'20128,022,252'Spatially-defined macrocyclic compounds useful for drug discovery'2011RE042624'Methods of using macrocyclic modulators of the ghrelin receptor'2011RE042013'Macrocyclic modulators of the ghrelin receptor'20107,550,431'Spatially-defined macrocycles incorporating peptide bond surrogates'20097,521,420'Macrocyclic antagonists of the motilin receptor'20097,491,695'Methods of using macrocyclic modulators of the ghrelin receptor'20097,476,653'Macrocyclic modulators of the ghrelin receptor'20097,452,862'Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists'20085,241,069'Carbonate intermediates for the synthesis of purine substituted cyclopentene derivatives'19935,126,452'Synthesis of purine substituted cyclopentene derivatives'1992

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1992–1993Based in Maryland Heights, MO, US· patent location history
2008–2013Patents assigned to TRANZYME PHARMA INC (14)· patent assignee history
2008–2011Based in Rock Forest, CA· patent location history
2009–2019Based in Sherbrooke, CA· patent location history
2009–2013Based in Québec, CA· patent location history
2012–2016Patents assigned to PETERSON MARK L (7)· patent assignee history
2012–2013Patents assigned to HOVEYDA HAMID R (6)· patent assignee history
2012–2016Patents assigned to FRASER GRAEME L (5)· patent assignee history
2013–2016Patents assigned to MARSAULT ERIC (5)· patent assignee history
2017Based in Chanhassen, MN, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
TRANZYME PHARMA INC142008–2013
PETERSON MARK Lself72012–2016
HOVEYDA HAMID R62012–2013
FRASER GRAEME L52012–2016
MARSAULT ERIC52013–2016
Locations
LocationPatentsSpan
Sherbrooke, CA92009–2019
Québec, CA82009–2013
Rock Forest, CA32008–2011
Chanhassen, Minnesota, US22017
Maryland Heights, MO, US21992–1993